The closing price of Ngm Biopharmaceuticals Inc (NASDAQ: NGM) was $1.56 for the day, down -0.64% from the previous closing price of $1.57. In other words, the price has decreased by -$0.0100 from its previous closing price. On the day, 1054541 shares were traded.
Ratios:
Our analysis of NGM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.79 and its Current Ratio is at 7.79. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 16 ’23 when COLUMN GROUP L P bought 5,840 shares for $0.62 per share. The transaction valued at 3,627 led to the insider holds 949,862 shares of the business.
COLUMN GROUP L P bought 5,840 shares of NGM for $3,627 on Nov 16 ’23. The Director now owns 949,862 shares after completing the transaction at $0.62 per share. On Nov 16 ’23, another insider, COLUMN GROUP L P, who serves as the Director of the company, bought 5,840 shares for $0.62 each. As a result, the insider paid 3,627 and bolstered with 949,862 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NGM now has a Market Capitalization of 129.37M and an Enterprise Value of -35.30M. For the stock, the TTM Price-to-Sale (P/S) ratio is 29.46 while its Price-to-Book (P/B) ratio in mrq is 0.87. Its current Enterprise Value per Revenue stands at -7.99 whereas that against EBITDA is 0.24.
Stock Price History:
Over the past 52 weeks, NGM has reached a high of $4.69, while it has fallen to a 52-week low of $0.60. The 50-Day Moving Average of the stock is 1.4866, while the 200-Day Moving Average is calculated to be 1.6551.
Shares Statistics:
NGM traded an average of 1.33M shares per day over the past three months and 779.91k shares per day over the past ten days. A total of 82.91M shares are outstanding, with a floating share count of 52.55M. Insiders hold about 37.04% of the company’s shares, while institutions hold 25.75% stake in the company. Shares short for NGM as of Feb 29, 2024 were 1.63M with a Short Ratio of 1.22, compared to 1.68M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.95% and a Short% of Float of 7.12%.
Earnings Estimates
The firm’s stock currently is rated by 4 analysts. On average, analysts expect EPS of -$0.35 for the current quarter, with a high estimate of -$0.29 and a low estimate of -$0.46, while EPS last year was -$0.58. The consensus estimate for the next quarter is -$0.31, with high estimates of -$0.26 and low estimates of -$0.39.
Analysts are recommending an EPS of between -$0.55 and -$1.61 for the fiscal current year, implying an average EPS of -$1.15. EPS for the following year is -$0.92, with 5 analysts recommending between -$0.38 and -$1.49.
